IMMUNIC, INC. - IMUX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 17, 2026 | SCHEDULE 13G | Avidity Partners Management LP | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Partners Management (GP) LLC | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Capital Partners Fund (GP) LP | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Capital Partners (GP) LLC | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Private Master Fund I LP | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Michael Gregory | 9.9% | 13,958,410 | View |
| Mar 04, 2026 | SCHEDULE 13G | Deep Track Capital, LP | 8.69% | 11,454,000 | View |
| Mar 04, 2026 | SCHEDULE 13G | Deep Track Biotechnology Master Fund, Ltd. | 6.79% | 8,953,630 | View |
| Mar 04, 2026 | SCHEDULE 13G | David Kroin | 8.69% | 11,454,000 | View |
| Mar 04, 2026 | SCHEDULE 13G | Deep Track Special Opportunities Fund, LP. | 1.9% | 2,500,370 | View |
| Feb 24, 2026 | SCHEDULE 13G | Commodore Capital LP | 9.9% | 13,350,121 | View |
| Feb 24, 2026 | SCHEDULE 13G | Commodore Capital Master LP | 9.9% | 13,350,121 | View |
| Feb 24, 2026 | SCHEDULE 13G | Robert Egen Atkinson | 9.9% | 13,350,121 | View |
| Feb 24, 2026 | SCHEDULE 13G | Michael Kramarz | 9.9% | 13,350,121 | View |
| Feb 24, 2026 | SCHEDULE 13G | Trails Edge Capital Partners, LP | 8.7% | 11,454,000 | View |
| Feb 24, 2026 | SCHEDULE 13G | Trails Edge Biotechnology Master Fund, LP | 8.7% | 11,454,000 | View |
| Feb 24, 2026 | SCHEDULE 13G | Ortav Yehudai | 8.7% | 11,454,000 | View |
| Feb 20, 2026 | SCHEDULE 13D | — | 7.4% | 10,113,585 | View |
| Feb 20, 2026 | SCHEDULE 13G | Vivo Opportunity Fund Holdings, L.P. | 9.99% | 29,126,906 | View |
| Feb 20, 2026 | SCHEDULE 13G | Vivo Opportunity, LLC | 9.99% | 29,126,906 | View |
| Feb 20, 2026 | SCHEDULE 13G | Vivo Opportunity Cayman Fund, L.P. | 9.99% | 2,942,094 | View |
| Feb 20, 2026 | SCHEDULE 13G | Vivo Opportunity Cayman, LLC | 9.99% | 2,942,094 | View |
| Feb 19, 2026 | SCHEDULE 13G | Soleus Capital Master Fund, L.P. | 5.5% | 6,792,000 | View |
| Feb 19, 2026 | SCHEDULE 13G | Soleus Capital, LLC | 5.5% | 6,792,000 | View |
| Feb 19, 2026 | SCHEDULE 13G | Soleus Capital Group, LLC | 5.5% | 6,792,000 | View |
| Feb 19, 2026 | SCHEDULE 13G | Soleus Capital Management, L.P. | 5.5% | 6,792,000 | View |
| Feb 19, 2026 | SCHEDULE 13G | Soleus GP, LLC | 5.5% | 6,792,000 | View |
| Feb 19, 2026 | SCHEDULE 13G | Guy Levy | 5.5% | 6,792,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Alyeska Investment Group, L.P. | 6.24% | 7,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Alyeska Fund GP, LLC | 6.24% | 7,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Anand Parekh | 6.24% | 7,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | 683 CAPITAL MANAGEMENT, LLC | 5.9% | 7,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | 683 CAPITAL PARTNERS, LP | 5.9% | 7,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Zweiman Ari | 5.9% | 7,500,000 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 8.22% | 10,378,406 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 8.22% | 10,378,406 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 8.22% | 10,378,406 | View |
| Feb 02, 2026 | SCHEDULE 13G/A | Aberdeen Group plc | 6.85% | 8,243,941 | View |
| Feb 02, 2026 | SCHEDULE 13G/A | abrdn Inc. | 6.85% | 8,243,941 | View |
| Dec 08, 2025 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 9.99% | 12,016,444 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Alyeska Investment Group, L.P. | 9.35% | 11,250,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Alyeska Fund GP, LLC | 9.35% | 11,250,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Anand Parekh | 9.35% | 11,250,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Partners Management LP | 4.8% | 4,699,411 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Partners Management (GP) LLC | 4.8% | 4,699,411 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Capital Partners Fund (GP) LP | 4.8% | 4,699,411 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Avidity Capital Partners (GP) LLC | 4.8% | 4,699,411 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Michael Gregory | 4.8% | 4,699,411 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Private Equity Fund III, L.P. | 1.1% | 1,060,457 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Private Equity GP III, LLC | 1.1% | 1,060,457 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus PE GP III, LLC | 1.1% | 1,060,457 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 0.5% | 519,550 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital, LLC | 0.5% | 519,550 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 0.5% | 519,550 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 1.6% | 1,580,007 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus GP, LLC | 1.6% | 1,580,007 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Guy Levy | 1.6% | 1,580,007 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.